Home › Sciex Receives China FDA Approval for Mass Spec System

Sciex Receives China FDA Approval for Mass Spec System

Jun 29, 2017

NEW YORK (GenomeWeb) – Sciex said today that its AB Sciex Triple Quad 4500MD LC-MS/MS system has been approved by the China Food and Drug Administration for use as a medical device.

With the approval, the system, which consists of the LC-MS/MS instrumentation along with Sciex's Analyst MD, Cliquid MD, and MultiQuant MD software, can be used in China for in vitro diagnostic testing.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Nov
15
Featured Webinar

Next-Generation Platforms for Strain Optimization: Reducing the Cost and Time for Commercializing Novel Biological Molecules

This webinar will discuss how Amyris, a biotechnology company that develops renewable products for a broad range of applications and industries, uses large-scale microbial engineering to support its manufacturing processes.

Dec
03
Featured Webinar

Application of a Novel ISH Approach to Elucidate Splice Variants in Schizophrenia

Sponsored by
Advanced Cell Diagnostics

This webinar will demonstrate how a research team at the National Institutes of Health evaluated a novel in situ hybridization approach and applied it to study splice variants related to schizophrenia.

What's Popular?

In Molecular Diagnostics

  1. Natera Waits for ACOG Guidance on Average-Risk NIPT; Pushes Ahead in Oncology, Transplantation

    Premium

  2. LabCorp, Sysmex, Diazyme, and Others Receive FDA Clearances for Assays, Diagnostic Systems in October

  3. EliTech Instrument Clearance Brings Unique Features to Mid-Size US Labs

    Premium

  4. Natera's Q3 Revenues Climb 17 Percent

  5. Rna Diagnostics Raises $5M in Series A Financing Round

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.